...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Due Dilligence

Corporate Update Presentation 2/4/2021

Posted by: BearDownAZ on Feb 05, 2021 06:15AM
URL: http://118009.choruscall.com/resverlogix/resverlogix20210204.pdf

Annual General Meeting Presentation 12/22/2020

Posted by: BearDownAZ on Feb 05, 2021 06:14AM
URL: https://www.resverlogix.com/upload/media...c8654179415f/rvx-2020-agm-final---cc.pdf

ASN Kidney Week BETonMACE CKD Oral Presentation 10/24/2020

Posted by: BearDownAZ on Oct 25, 2020 06:21PM
URL: https://www.resverlogix.com/upload/media...8d8/kalantar_apabetalone_asn2020_v05.pdf
Resverlogix Corp. Links

BET Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection

Posted by: BearDownAZ on Mar 16, 2021 10:48AM
URL: https://www.cell.com/cell/fulltext/S0092-8674(21)00354-8

Transcript of 2/4/21 Corporate Update (unofficial, c/o imtesty)

Posted by: BearDownAZ on Feb 12, 2021 09:42AM
URL: https://agoracom.com/ir/Resverlogix/foru...call-02-04-2021/messages/2303371#message

Corporate Update Presentation 2/4/2021

Posted by: BearDownAZ on Feb 05, 2021 06:15AM
URL: http://118009.choruscall.com/resverlogix/resverlogix20210204.pdf

Annual General Meeting Presentation 12/22/2020

Posted by: BearDownAZ on Feb 05, 2021 06:14AM
URL: https://www.resverlogix.com/upload/media...c8654179415f/rvx-2020-agm-final---cc.pdf

Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study

Posted by: BearDownAZ on Jan 12, 2021 08:05AM
URL: https://cardiab.biomedcentral.com/articles/10.1186/s12933-020-01199-x

AGM 12/22/2020 transcript c/o imtesty

Posted by: BearDownAZ on Jan 06, 2021 10:54AM
URL: https://agoracom.com/ir/Resverlogix/foru...ough-transcript/messages/2295324#message

AHA 2020: Reduction in the Risk of Major Adverse Cardiovascular Events with Apabetalone, a BET Protein Inhibitor, in Patients withRecent Acute Coronary Syndrome and Type 2 Diabetes According to Insulin Treatment: Analysis of the BETonMACE Trial

Posted by: BearDownAZ on Nov 16, 2020 10:23AM
URL: https://www.resverlogix.com/upload/media...lin-aha-2020_05-nov-2020---read-only.pdf

AHA 2020: BET Protein Inhibitor Apabetalone Suppresses Inflammatory Hyperactivation of Monocytes from Patients with Cardiovascular Disease and Type 2 Diabetes

Posted by: BearDownAZ on Nov 14, 2020 05:28PM
URL: https://www.resverlogix.com/upload/media...ee0/2020-10-05-mela-aha-presentation.pdf

AHA 2020: Apabetalone (RVX-208) Reduces ACE2 Expression in Human Cell Culture Systems, Which Could Attenuate SARS-CoV-2 Viral Entry

Posted by: BearDownAZ on Nov 14, 2020 05:27PM
URL: https://www.resverlogix.com/upload/media...ha-2020-covid-19_eposter.final.dg.lf.pdf

Cardiovascular Therapeutics article: Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease

Posted by: BearDownAZ on Nov 14, 2020 05:25PM
URL: https://www.hindawi.com/journals/cdtp/2020/9397109/